Cancer Vaccines Led To Long-term Survival For Patients With Metastatic Melanoma

Medical researchers have released promising data from a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose disease had been minimized by other therapies.

Read the whole article on Science Daily

More from Science Daily